Inventor · disambiguated record
Hanlin Feng
Also filed as: FENG HANLIN
5 granted patents·3 pending applications·5 citations·filing 2003–2021
64Inventor score
Files withSHENZHEN NEPTUNUS PHARMACEUTIC3SHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD3KANG HUI1ZHAO JINHUA1
Top patents by PatentIndex Score
8 records- 0178US8809300B2Depolymerized glycosaminoglycan from Thelenota ananas and preparation method thereofZHAO JINHUA·Filed 2010·Granted Aug 19, 2014·5 cites·20 claims
- 0253US2008261902A1Pharmaceutical composition containing polydatin and its applicationSHENZHEN NEPTUNUS PHARMACEUTIC·Filed 2008·Application pending·0 cites
- 0348US12391706B2Multi-target tyrosine kinase inhibitorSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2021·Granted Aug 19, 2025·0 cites·13 claims
- 0448US2008176810A1Use of 3, 4', 5-Trihydroxy-Stilbene-3-Beta-D-glucoside in Prepartion of Medicines For Treating and/or Preventing Ischemic Heart DiseaseSHENZHEN NEPTUNUS PHARMACEUTIC·Filed 2005·Application pending·0 cites
- 0545US9957237B2Crystal form of neptinib di-p-methylbenzenesulfonate, preparation method thereof, and pharmaceutical composition containing sameSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2015·Granted May 1, 2018·0 cites·8 claims
- 0641US10640492B2Tubulin inhibitorSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2017·Granted May 5, 2020·0 cites·7 claims
- 0736US2008009453A1Pharmceutical Compositions Containing Polydatin or Its Salts and Their ApplicationSHENZHEN NEPTUNUS PHARMACEUTIC·Filed 2003·Application pending·0 cites
- 0833US8575115B2Crystalline form I of 3,4′5-trihydroxy-stilbene-3-β-D glucosideKANG HUI·Filed 2006·Granted Nov 5, 2013·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Hanlin Feng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →